azacitidine has been researched along with Acute Promyelocytic Leukemia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, H; Gao, X; Li, Y; Wang, W; Xue, Y; Yao, D | 1 |
| Herold, T; Hiddemann, W; Rausch, C; Spiekermann, K; von Bergwelt-Baildon, M | 1 |
| Baker, K; Banos, A; Bixby, D; Braun, T; Carulli, J; Cluzeau, T; Cook, RJ; de Botton, S; Eaton, M; Fenaux, P; Fiore, C; Hodgson, G; Jurcic, JG; Kang-Fortner, Q; Kelly, MJ; Liesveld, JL; Madigan, K; McKeown, M; Paul, S; Rizzieri, DA; Roboz, GJ; Roth, DA; Rousselot, P; Savona, MR; Sekeres, MA; Stein, EM; Stephens, K; Vigil, C; Volkert, A | 1 |
| Abboud, CN; Cashen, AF; Dipersio, JF; Jacoby, M; Niu, H; Pusic, I; Schroeder, MA; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Welch, JS; Westervelt, P | 1 |
| Wiernik, PH | 1 |
| Jaksic, O; Kusec, R; Lasan-Trcic, R; Lucijanic, M; Pejsa, V; Stoos-Veic, T | 1 |
| Chen, JJ; Chen, Y; Lin, DJ; Long, ZJ; Wu, X; Xiao, RZ; Xiong, MJ | 1 |
| Luo, Q; Su, Y; Xian, Y; Xu, H; Xu, Y; Yu, J | 1 |
| Chan, WW; Chim, CS; Kwong, YL; Pang, A | 1 |
| Andreeff, M; Contractor, R; Issa, JP; Jin, L; Kondo, Y; Konopleva, M; Miyake, K; Miyake, N; Nagaoka, I; Ohsaka, A; Ruvolo, V; Tabe, Y; Tsutsumi-Ishii, Y | 1 |
| Santini, V | 1 |
| Darzynkiewicz, Z; Del Bino, G; Li, X; Traganos, F | 1 |
| Bhatia, U; Darzynkiewicz, Z; Gong, J; Li, X; Murakami, T; Traganos, F | 1 |
| He, ZX; Rao, H | 1 |
| Ayabe, H; Darzynkiwicz, Z; Hara, S; Tagawa, Y | 1 |
| Marx, J | 1 |
| Corsaro, M; Di Croce, L; Fanelli, M; Faretta, M; Fazi, F; Fuks, F; Kouzarides, T; Lo Coco, F; Minucci, S; Nervi, C; Pelicci, PG; Raker, VA | 1 |
| Samid, D; Shack, S; Sherman, LT | 1 |
| Laliberté, J; Momparler, RL | 1 |
2 review(s) available for azacitidine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.
Topics: Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Molecular Targeted Therapy; Prognosis; Remission Induction; Treatment Outcome | 2014 |
A selective activity of DNMTi decitabine on AML1ETO positive cells?
Topics: Animals; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; Core Binding Factor Alpha 2 Subunit; Cyclin-Dependent Kinase Inhibitor p15; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; RUNX1 Translocation Partner 1 Protein | 2007 |
1 trial(s) available for azacitidine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
Topics: Administration, Oral; Aged; Aged, 80 and over; Animals; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Azacitidine; Bexarotene; Decitabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Gene Expression; Gene Expression Profiling; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Mice; Middle Aged; Receptors, Retinoic Acid; Recurrence; Retinoic Acid Receptor alpha; Retinoid X Receptor alpha; Tetrahydronaphthalenes; Tumor Cells, Cultured | 2014 |
16 other study(ies) available for azacitidine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Central nervous system relapse of acute promyelocytic leukemia treated by oral Venetoclax with Azacitidine achieved complete remission.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Recurrence; Remission Induction; Sulfonamides | 2022 |
[Acute Myeloid Leukemia - Update 2022].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Azacitidine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Tretinoin | 2022 |
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML.
Topics: Azacitidine; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Myelodysplastic Syndromes; Retinoic Acid Receptor alpha | 2023 |
Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 13; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Translocation, Genetic | 2015 |
[Decitabine inhibits cell proliferation and induces apoptosis of all-trans retinoid acid-resistant acute promyelocytic leukemia NB4-R2 cell line].
Topics: Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; Decitabine; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Tretinoin | 2012 |
Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.
Topics: Apoptosis Regulatory Proteins; Azacitidine; Calcium-Calmodulin-Dependent Protein Kinases; Cell Growth Processes; Cell Line, Tumor; CpG Islands; Death-Associated Protein Kinases; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Genes, p16; Genes, Regulator; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Promoter Regions, Genetic; Tumor Suppressor Proteins | 2012 |
Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor.
Topics: Adaptor Proteins, Signal Transducing; Azacitidine; Biomarkers, Tumor; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Leukemia, Promyelocytic, Acute; Methylation; Multivariate Analysis; Prognosis; Recurrence; Remission Induction; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Sensitivity and Specificity; Survival Rate; Tretinoin; Tumor Cells, Cultured | 2006 |
PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.
Topics: Antineoplastic Agents; Azacitidine; Core Binding Factor Alpha 2 Subunit; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Histone Deacetylases; HL-60 Cells; Humans; K562 Cells; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Receptors, Retinoic Acid; RNA, Messenger; RNA, Neoplasm; RUNX1 Translocation Partner 1 Protein; Translocation, Genetic; Tretinoin; U937 Cells | 2006 |
Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs.
Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Camptothecin; Cell Cycle; Cell Differentiation; Dimethyl Sulfoxide; DNA, Neoplasm; Humans; Hyperthermia, Induced; Leukemia, Promyelocytic, Acute; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 1994 |
Induction of apoptosis by 5-azacytidine: drug concentration-dependent differences in cell cycle specificity.
Topics: Apoptosis; Azacitidine; Cell Cycle; DNA Replication; DNA, Neoplasm; Flow Cytometry; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Sensitivity and Specificity; Tumor Cells, Cultured | 1995 |
The effect of 5-azacytidine (5-aza-CR) and its analogue on cell differentiation and DNA methylation of HL-60 cells.
Topics: Antineoplastic Agents; Azacitidine; Cell Differentiation; Decitabine; DNA-Cytosine Methylases; DNA-Directed RNA Polymerases; DNA, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Methylation; Tumor Cells, Cultured | 1993 |
[Analysis of drug-induced apoptosis in human leukemic cell line (HL-60)].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Azacitidine; Camptothecin; Cell Cycle; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Tosylphenylalanyl Chloromethyl Ketone | 1998 |
Cancer research. Leukemia protein spurs gene silencing.
Topics: Azacitidine; Cell Division; Cell Transformation, Neoplastic; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Silencing; Genes, Tumor Suppressor; Humans; Leukemia, Promyelocytic, Acute; Leukocytes; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Receptors, Retinoic Acid; Tretinoin; Zinc | 2002 |
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor.
Topics: Azacitidine; Binding Sites; Cell Differentiation; Cell Line; Cell Nucleus; Cell Transformation, Neoplastic; Cloning, Molecular; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Exons; Gene Expression; Gene Silencing; Histone Deacetylases; Humans; Leukemia, Promyelocytic, Acute; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Receptors, Retinoic Acid; Recombinant Fusion Proteins; Transcription Factors; Tretinoin; Tumor Cells, Cultured; Zinc | 2002 |
Phenylacetate: a novel nontoxic inducer of tumor cell differentiation.
Topics: Adipose Tissue; Animals; Antineoplastic Agents; Azacitidine; Cell Differentiation; Cell Division; Cell Line; Cell Transformation, Neoplastic; Decitabine; Gene Expression; Genes, myc; Humans; Leukemia, Promyelocytic, Acute; Mice; Mice, Nude; Phenylacetates; RNA, Ribosomal | 1992 |
Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine.
Topics: Antineoplastic Agents; Azacitidine; Cell Differentiation; Cytidine Deaminase; Decitabine; DNA, Neoplasm; Enzyme Induction; Humans; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured | 1990 |